541 related articles for article (PubMed ID: 9215638)
21. GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor.
Shi W; Sun C; He B; Xiong W; Shi X; Yao D; Cao X
J Cell Biol; 2004 Jan; 164(2):291-300. PubMed ID: 14718519
[TBL] [Abstract][Full Text] [Related]
22. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3.
Dennler S; Huet S; Gauthier JM
Oncogene; 1999 Feb; 18(8):1643-8. PubMed ID: 10102636
[TBL] [Abstract][Full Text] [Related]
23. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling.
Abdollah S; Macías-Silva M; Tsukazaki T; Hayashi H; Attisano L; Wrana JL
J Biol Chem; 1997 Oct; 272(44):27678-85. PubMed ID: 9346908
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.
Ge R; Rajeev V; Subramanian G; Reiss KA; Liu D; Higgins L; Joly A; Dugar S; Chakravarty J; Henson M; McEnroe G; Schreiner G; Reiss M
Biochem Pharmacol; 2004 Jul; 68(1):41-50. PubMed ID: 15183116
[TBL] [Abstract][Full Text] [Related]
25. Genomic locus and promoter region of rat Smad7, an important antagonist of TGFbeta signaling.
Stopa M; Benes V; Ansorge W; Gressner AM; Dooley S
Mamm Genome; 2000 Feb; 11(2):169-76. PubMed ID: 10656934
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
27. Structural basis of Smad2 recognition by the Smad anchor for receptor activation.
Wu G; Chen YG; Ozdamar B; Gyuricza CA; Chong PA; Wrana JL; Massagué J; Shi Y
Science; 2000 Jan; 287(5450):92-7. PubMed ID: 10615055
[TBL] [Abstract][Full Text] [Related]
28. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
29. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
30. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.
Kawabata M; Inoue H; Hanyu A; Imamura T; Miyazono K
EMBO J; 1998 Jul; 17(14):4056-65. PubMed ID: 9670020
[TBL] [Abstract][Full Text] [Related]
31. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
32. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.
Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J
Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614
[TBL] [Abstract][Full Text] [Related]
33. Smad2 phosphorylation by type I receptor: contribution of arginine 462 and cysteine 463 In the C terminus of Smad2 for specificity.
Yakymovych I; Heldin CH; Souchelnytskyi S
J Biol Chem; 2004 Aug; 279(34):35781-7. PubMed ID: 15210694
[TBL] [Abstract][Full Text] [Related]
34. Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240.
Abdel-Wahab N; Wicks SJ; Mason RM; Chantry A
Biochem J; 2002 Mar; 362(Pt 3):643-9. PubMed ID: 11879191
[TBL] [Abstract][Full Text] [Related]
35. Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus.
Jiang B; Zhang JS; Du J; Urrutia R; Barnard J
Cell Signal; 2003 Jul; 15(7):699-708. PubMed ID: 12742230
[TBL] [Abstract][Full Text] [Related]
36. CIN85 modulates TGFβ signaling by promoting the presentation of TGFβ receptors on the cell surface.
Yakymovych I; Yakymovych M; Zang G; Mu Y; Bergh A; Landström M; Heldin CH
J Cell Biol; 2015 Jul; 210(2):319-32. PubMed ID: 26169354
[TBL] [Abstract][Full Text] [Related]
37. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
[TBL] [Abstract][Full Text] [Related]
38. Swift is a novel BRCT domain coactivator of Smad2 in transforming growth factor beta signaling.
Shimizu K; Bourillot PY; Nielsen SJ; Zorn AM; Gurdon JB
Mol Cell Biol; 2001 Jun; 21(12):3901-12. PubMed ID: 11359898
[TBL] [Abstract][Full Text] [Related]
39. The G protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal transduction.
Ho J; Cocolakis E; Dumas VM; Posner BI; Laporte SA; Lebrun JJ
EMBO J; 2005 Sep; 24(18):3247-58. PubMed ID: 16121194
[TBL] [Abstract][Full Text] [Related]
40. Control of Smad7 stability by competition between acetylation and ubiquitination.
Grönroos E; Hellman U; Heldin CH; Ericsson J
Mol Cell; 2002 Sep; 10(3):483-93. PubMed ID: 12408818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
